Price T Rowe Associates Inc Kura Oncology, Inc. Transaction History

Price T Rowe Associates Inc

$812 Billion
Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 31,718 shares of KURA stock, worth $197,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,718

Previous 28,070 13.0%

Holding current value

$197,920

Previous $245,000 14.29%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$6.6 - $9.05 $24,076 - $33,014	3,648 Added 13.0%	31,718 $210,000
Q4 2024 Feb 14, 2025	BUY	$8.51 - $19.21 $36,967 - $83,448	4,344 Added 18.31%	28,070 $245,000
Q3 2024 Nov 14, 2024	BUY	$18.57 - $23.23 $12,479 - $15,610	672 Added 2.91%	23,726 $464,000
Q2 2024 Aug 14, 2024	BUY	$17.53 - $22.98 $50,942 - $66,779	2,906 Added 14.42%	23,054 $475,000
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $39,454 - $69,178	2,940 Added 17.09%	20,148 $430,000
Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $133,855 - $253,936	-17,659 Reduced 50.65%	17,208 $248,000
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $88,611 - $124,518	10,499 Added 43.09%	34,867 $318,000
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $5,848 - $8,505	608 Added 2.56%	24,368 $258,000
Q1 2023 May 15, 2023	BUY	$10.71 - $14.6 $10,442 - $14,235	975 Added 4.28%	23,760 $291,000
Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $44,504 - $66,974	-3,963 Reduced 14.82%	22,785 $283,000
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $132,686 - $214,883	-11,048 Reduced 29.23%	26,748 $366,000
Q2 2022 Aug 15, 2022	BUY	$10.71 - $18.33 $4,530 - $7,753	423 Added 1.13%	37,796 $693,000
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $180,186 - $259,726	15,296 Added 69.28%	37,373 $601,000
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $211,137 - $338,130	-17,278 Reduced 43.9%	22,077 $309,000
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $97,701 - $137,617	6,336 Added 19.19%	39,355 $737,000
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $26,542 - $38,037	1,273 Added 4.01%	33,019 $688,000
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $196,119 - $310,145	7,924 Added 33.26%	31,746 $897,000
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $690,838 - $991,471	23,822 New	23,822 $778,000

Others Institutions Holding KURA

# of Institutions

189

Shares Held

78.6M

Call Options Held

76K

Put Options Held

85.8K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $417M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Kura Oncology, Inc. Transaction History